{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:28:07Z","timestamp":1794547687115,"version":"4.9.1"},"reference-count":16,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J of Pharm Policy and Pract"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Therapeutic drug monitoring (TDM) of Vancomycin (VCM) is required to prevent inappropriate dosage-associated bacterial resistance, therapeutic failure, and toxicities in pediatrics. Anecdotal experience and studies show that many healthcare institutions confront barriers while implementing TDM services, this study aimed to assess a pharmacist-directed VCM\u2013TDM service for optimizing patient care in our institution.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Patients aged 1\u00a0month\u201318\u00a0years who received intravenous VCM were included in this quasi-experimental study. The pre-implementation phase (March\u2013June 2018) consisted of retrospective assessment of pediatric patients, the interventional phase (July 2018 to February 2020) included educational programs and the post-implementation phase (March\u2013June 2020) evaluated the participants based on pharmacist-directed VCM\u2013TDM services as a collaborative-practice model including clinical and inpatient pharmacists to provide 24\/7 TDM services. Outcomes of the study included the mean difference in the number of optimal (i) prescribed initial VCM doses (primary) (ii) dosage adjustments and (iii) VCM-sampling time (secondary). After ethical approval, data were collected retrospectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A hundred patients were there in each phase. The number of cases who were correctly prescribed initial VCM doses was significantly higher in the post-implementation phase, mean difference of 0.22, [95% CI (0.142\u20130.0.358), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001]. Patients who had correct dosage adjustments in the post-implementation phase also had higher statistical significance, mean difference of 0.29, [95% CI (0.152\u20130.423), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05]. More correct practices of VCM-levels timing were observed in the post-implementation phase, mean difference of 0.15, [95% CI (\u2212\u20090.053\u20130.264), <jats:italic>p<\/jats:italic>\u2009=\u20090.079].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study showed the significant role of pharmacist-directed TDM services to optimize the correct prescribing of initial VCM doses and dose adjustments.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40545-021-00383-y","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T18:37:29Z","timestamp":1638297449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacist-directed vancomycin therapeutic drug monitoring in pediatric patients: a collaborative-practice model"],"prefix":"10.1080","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9836-1696","authenticated-orcid":false,"given":"Kashif","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahila","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gul","family":"Ambreen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sohail","family":"Salat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"383_CR1","doi-asserted-by":"crossref","unstructured":"Pharmacists ASoH-S. ASHP statement on the pharmacist\u2019s role in clinical pharmacokinetic monitoring. Am J Health-Syst Pharm. 1998;55(16):1726\u20137.","DOI":"10.1093\/ajhp\/55.16.1726"},{"issue":"1","key":"383_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3904\/kjim.2009.24.1.1","volume":"24","author":"J-S Kang","year":"2009","unstructured":"Kang J-S, Lee M-H. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009;24(1):1.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"383_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1592\/phco.28.1.1","volume":"28","author":"C Bond","year":"2008","unstructured":"Bond C, Raehl CL. 2006 national clinical pharmacy services survey: clinical pharmacy services, collaborative drug management, medication errors, and pharmacy technology. Pharmacotherapy J Hum Pharmacol Drug Therapy. 2008;28(1):1\u201313.","journal-title":"Pharmacotherapy J Hum Pharmacol Drug Therapy."},{"issue":"3","key":"383_CR4","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00134-007-0918-2","volume":"34","author":"JM LeBlanc","year":"2008","unstructured":"LeBlanc JM, Seoane-Vazquez EC, Arbo TC, Dasta JF. International critical care hospital pharmacist activities. Intensive Care Med. 2008;34(3):538\u201342.","journal-title":"Intensive Care Med"},{"issue":"4","key":"383_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/CNQ.0b013e3182a11057","volume":"36","author":"LV Jurado","year":"2013","unstructured":"Jurado LV, Steelman JD. The role of the pharmacist in the intensive care unit. Crit Care Nurs Q. 2013;36(4):407\u201314.","journal-title":"Crit Care Nurs Q"},{"issue":"6","key":"383_CR6","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s11096-015-0183-3","volume":"37","author":"N Kheir","year":"2015","unstructured":"Kheir N, Awaisu A, Gad H, Elazzazy S, Jibril F, Gajam M. Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied. Int J Clin Pharm. 2015;37(6):1180\u20137.","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"383_CR7","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1177\/1060028015587900","volume":"49","author":"KA Marquis","year":"2015","unstructured":"Marquis KA, DeGrado JR, Labonville S, Kubiak DW, Szumita PM. Evaluation of a pharmacist-directed vancomycin dosing and monitoring pilot program at a tertiary academic medical center. Ann Pharmacother. 2015;49(9):1009\u201314.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"383_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1248\/yakushi.14-00222-3","volume":"135","author":"K Kawamura","year":"2015","unstructured":"Kawamura K, Son D, Nakashima M, Utsumi M. Elucidating obstructive factors for IPW from the pharmacist position in clinical practice. Yakugaku zasshi J Pharm Soc Japan. 2015;135(1):123\u20139.","journal-title":"Yakugaku zasshi J Pharm Soc Japan"},{"issue":"4","key":"383_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jsps.2012.12.006","volume":"21","author":"MS Alsultan","year":"2013","unstructured":"Alsultan MS, Mayet AY, Khurshid F, Al-Jedai AH. Hospital pharmacy practice in Saudi Arabia: drug monitoring and patient education in the Riyadh region. Saudi Pharm J. 2013;21(4):361\u201370.","journal-title":"Saudi Pharm J"},{"issue":"1","key":"383_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6963-14-93","volume":"14","author":"M McLeod","year":"2014","unstructured":"McLeod M, Ahmed Z, Barber N, Franklin BD. A national survey of inpatient medication systems in English NHS hospitals. BMC Health Serv Res. 2014;14(1):1\u201311.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"383_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/pharmacy7010020","volume":"7","author":"AF Alhameed","year":"2019","unstructured":"Alhameed AF, Khansa SA, Hasan H, Ismail S, Aseeri M. Bridging the gap between theory and practice; the active role of inpatient pharmacists in therapeutic drug monitoring. Pharmacy. 2019;7(1):20.","journal-title":"Pharmacy"},{"issue":"11","key":"383_CR12","first-page":"1500","volume":"92","author":"C Ratanajamit","year":"2011","unstructured":"Ratanajamit C, Kaewpibal P, Setthawacharavanich S, Faroongsarng D. Effect of pharmacist participation in the health care team on therapeutic drug monitoring utilization for antiepileptic drugs. J Med Assoc Thai. 2011;92(11):1500.","journal-title":"J Med Assoc Thai"},{"key":"383_CR13","doi-asserted-by":"publisher","first-page":"205031212095105","DOI":"10.1177\/2050312120951058","volume":"8","author":"M Salem","year":"2020","unstructured":"Salem M, Khalil A, Mohamed A, Elmasoudi A. Evaluation of vancomycin initial trough levels in children: a 1-year retrospective study. SAGE Open Med. 2020;8:2050312120951058.","journal-title":"SAGE Open Med"},{"issue":"1","key":"383_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82\u201398.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"383_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.2146\/ajhp080625","volume":"67","author":"L McCluggage","year":"2010","unstructured":"McCluggage L, Lee K, Potter T, Dugger R, Pakyz A. Implementation and evaluation of vancomycin nomogram guidelines in a computerized prescriber-order-entry system. Am J Health Syst Pharm. 2010;67(1):70\u20135.","journal-title":"Am J Health Syst Pharm"},{"key":"383_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4172\/2329-6887.1000219","volume":"4","author":"N Damfu","year":"2016","unstructured":"Damfu N, Aseeri M, Davis A, Hasan H, Ismail S. The impact of pharmacist led vancomycin order set implementation in a computerized-prescriber-order-entry (CPOE) system at a tertiary care centre: a quasi experimental study. J Pharmacovigil. 2016;4:219.","journal-title":"J Pharmacovigil"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40545-021-00383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40545-021-00383-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40545-021-00383-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T10:53:58Z","timestamp":1704279238000},"score":1,"resource":{"primary":{"URL":"https:\/\/joppp.biomedcentral.com\/articles\/10.1186\/s40545-021-00383-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["383"],"URL":"https:\/\/doi.org\/10.1186\/s40545-021-00383-y","relation":{},"ISSN":["2052-3211"],"issn-type":[{"value":"2052-3211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Before performing this study, ethical approval was taken from the institutional ethical committee of Aga Khan University Hospital (ERC # 2020-5150-11679) and informed consent from a parent or guardian for participants was waived by ERC as all the data was collected retrospectively.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and consent to participate"}},{"value":"The institutional Ethical Review Committee (ERC) and waived the need for written informed consent for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}